Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB2 | P05107 | 1/20 | 0.38 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.38 |
| ▸ | ITGAL | P20701 | 1/20 | 0.38 |
| ▸ | SLC9A1 | P19634 | 3/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 12/20 | 0.37 |
| ▸ | SLC9A5 | Q14940 | 1/20 | 0.36 |
| ▸ | SLC9A2 | Q9UBY0 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 10/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CRHBP | P24387 | 2/20 | 0.34 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL95880 | 0.89 | MTNR1A (0.36) | ITGB2ICAM1ITGALSLC9A1MTNR1B | |
| SCHEMBL14304553 | 0.82 | ITGB2 (0.39) | ITGB2ICAM1ITGALSLC9A1MTNR1B | |
| SCHEMBL97610 | 0.74 | KDM4E (0.45) | ITGB2ICAM1ITGALMTNR1ALMNA | |
| SCHEMBL7701503 | 0.74 | MTNR1B (0.39) | ITGB2ICAM1ITGALSLC9A1MTNR1B | |
| SCHEMBL5543467 | 0.74 | ITGB2 (0.42) | ITGB2ICAM1ITGALSLC9A1MTNR1B | |
| SCHEMBL21224311 | 0.72 | ITGB2 (0.37) | ITGB2ICAM1ITGALMTNR1BKMT2A | |
| SCHEMBL30289551 | 0.72 | ITGB2 (0.37) | ITGB2ICAM1ITGALMTNR1BKMT2A | |
| SCHEMBL29386706 | 0.71 | KDM4E (0.41) | ITGB2ICAM1ITGALSLC9A1MTNR1B | |
| SCHEMBL6187776 | 0.71 | KDM4E (0.41) | ITGB2ICAM1ITGALSLC9A1MTNR1B | |
| SCHEMBL8081108 | 0.69 | MAP3K14 (0.47) | ITGB2ICAM1ITGALSLC9A1MTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150322094-A1 | USE OF SUBSTITUTED 2,3-DIHYDRO-1-BENZOFURAN-4-CARBOXYLIC ACIDS OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | BAYER CROPSCIENCE AG (DE) | 2015-11-12 | — | — | US | disclosed |
| CN-104780761-A | Use of substituted 2, 3-dihydro-1-benzofuran-4-carboxylic acids or salts thereof as active substances against abiotic plant stress | BAYER CROPSCIENCE AG | 2015-07-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150322094-A1 | USE OF SUBSTITUTED 2,3-DIHYDRO-1-BENZOFURAN-4-CARBOXYLIC ACIDS OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | CAT, HSF1, HPD | ITGB2 4864/4885ICAM1 4719/4885ITGAL 4868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.